Genetic basis of autoimmune adrenal deficiency

Current Opinion in Endocrinology and Diabetes

Volumn 9, Issue 3, 2002, Pages 237-243

  Gottlieb, Peter A ^a   Fain, Pamela R ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; HLA DR3 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; STEROID 21 MONOOXYGENASE;

ADDISON DISEASE; ADRENAL INSUFFICIENCY; AUTOIMMUNITY; FAMILY HISTORY; GENE LOCATION; GENE LOCUS; GENETIC SUSCEPTIBILITY; HLA TYPING; HUMAN; IMMUNOPATHOGENESIS; REVIEW; RISK FACTOR;

EID: 0036308449     PISSN: 10683097     EISSN: None     Source Type: Journal    
DOI: 10.1097/00060793-200206000-00005     Document Type: Review

References (73)

1. Association of Addison's disease with autoimmune disorders - A long-term observation of 180 patients
2. Eighty-six cases of Addison's disease
3. Etiological diagnosis of primary adrenal insufficiency using an original flowchart of immune and biochemical markers
4. The prevalence of Addison's disease in Coventry, UK
5. Autoimmunity in isolated Addison's disease and in polyglandular autoimmune diseases type 1, 2 and 4
6. Autoimmune adrenal disease
7. Clinical Review 130: Addison's Disease 2001
8. Recent advances in the molecular genetics of congenital and acquired primary adrenocortical failure
9. Polyglandular autoimmune diseases
10. Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED)
11. Clinical review 93: Autoimmune polyglandular disease type1
12. Clinical variation of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) in a series of 68 patients
13. The expression of autoimmune polyglandular disease type I appears associated with several HLA-A antigens but not with HLA-DR
14. The polyglandular deficiency sydnrome: A new variant in Persian Jews
15. Polyglandular autoimmune sydnrome type I among Iranian Jews
16. A common mutation in Sardinian autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy patients
17. APECED mutations in the autoimmune regulator (AIRE) gene
18. Diseases of the adrenal cortex
19. Addison's disease
20. Clinical problem-solving. Just in time
21. My Addison's disease
22. Epidemiological and clinical picture of Addison's disease
23. Is the prevalence of Addison's disease underestimated?
24. Autoantibodies to steroidogenic enzymes in autoimmune polyglandular syndrome, Addison's disease, and premature ovarian failure
25. Immunoprecipitation of steroidogenic enzyme autoantigens with autoimmune polyglandular syndrome type I (APSI) sera: Further evidence for independent humoral immunity to P450c17 and P450c21
26. Identification by molecular cloning of an autoantigen association with Addison's disease as steroid 17-hydroxylase
27. 21-Hydroxylase, a major autoantigen in idiopathic Addison's disease
28. Autoantibodies to cytochrome P450 enzymes P450ssc, P450c17, and P450c21 in autoimmune polyglandular disease types I and II an in isolated Addison's disease
29. Steroid 21-hydroxylase is a major autoantigen involved in adult onset autoimmune Addison's disease
30. Autoantibodies against recombinant human steroidogenic enzymes 21-hydroxylase, side-chain cleavage and 17α-hydroxylase in Addison's disease and autoimmune polyendocrine syndrome type III
31. Autoantibodies to adrenal cytochrome P450 antigens in isolated Addison's disease and autoimmune polyendocrine syndrome type II
32. Adrenal autoantibodies and organ-specific autoimmunity in patients with Addison's disease
33. High-throughput radioassays for autoantibodies to recombinant autoantigens
34. Thyroid autoantibodies
35. Polyglandular autoimmune syndrome type II in patients with idiopathic Addison's disease
36. Associated autoimmunity in Addison's disease
37. 21-Hydroxylase autoantibodies in adult patients with endocrine autoimmune diseases are highly specific for Addison's disease
38. Clinical presentation of thyroid dysfunction and Addison's disease in young adults with type 1 diabetes
39. Steroid 21-hydroxylase autoantibodies in insulin-dependent diabetes mellitus
40. DRB1-04 and DQ alleles: Expression of 21-hydroxylase autoantibodies and risk of progression to Addison's Disease
41. I. Adrenal cortex and steroid 21-hydroxylase autoantibodies in adult patients with organ-specific autoimmune diseases: Markers of low progression to clinical Addison's disease
42. II. Adrenal cortex and steroid 21-hydroxylase autoantibodies in children with organ-specific autoimmune diseases: Markers of high progression to clinical Addison's disease
43. Adrenocortical insufficiency
44. Autoimmune Addison's disease
45. Autoimmune adrenocortical failure in Norway. Autoantibodies and HLA class II associations related to clinical features
46. Evidence that autoimmunity in man is a Mendelian dominant trait
47. Complex segregation analysis of antibodies to thyroid peroxidase in Old Order Amish families
48. Complex segregation analysis of antibodies to thyroid peroxidase in Old Order Amish families
49. Autosomal dominant inheritance of autoantibodies to thyroid peroxidase and thyroglobulin - Studies in families not selected for autoimmune thyroid disease
50. Complex segregation analysis of thyroid autoantibodies: Are they inherited as an autosomal dominant trait?
51. Complete sequence and the gene map of a human major histocompatibility complex
52. MLC typing in juvenile diabetes mellitus and idiopathic Addison's disease
53. Inherited susceptibility to autoimmune Addison's disease is linked to human leukocyte antigens-DR3 and/or DR4, except when associated with type 1 autoimmune polyglandular syndrome
54. Addison's disease: Immunologic aspects
55. MHC class II and III in Addison's disease. MHC alleles do not predict autoantibody specificity and no independent role for 21-hydroxylase gene polymorphism in disease susceptibility
56. The genetic susceptibility to type 1 (insulin-dependent) diabetes mellitus and the autoimmune thyroid diseases
57. Genetics of type 1A diabetes
58. The genetic basis for the association of the 8.1 ancestral haplotype (A1, B8, DR3) with multiple immunopathologic diseases
59. Susceptibility and resistance alleles of human leukocyte antigen (HLA) DQA1 and HLA DQB1 are shared in endocrine autoimmune disease
60. Histocompatibility leukocyte antigens and closely linked immunomodulatory genes in autoimmune thyroid disease
61. Steroid 21-hydroxylase gene polymorphism in Addison's disease patients
62. HLA complex genes in type 1 diabetes and other autoimmune diseases. Which genes are involved?
63. Microsatellite polymorphism of the MHC class I chain-related (MIC-A and MIC-B) genes marks the risk for autoimmune Addison's disease
64. Although DR3-DQB1.0201 may be associated with multiple component diseases of the autoimmune polyglandular syndromes, the human leukocyte antigen DR4-DQB1.0302 haplotype is implicated only in β-cell autoimmunity
65. The role of HLA class II genes in insulin-dependent diabetes mellitus: Molecular analysis of 180 Caucasian, multiplex families
66. Codon 17 polymorphism of the cytotoxic T lymphocyte antigen 4 gene in Hashimoto's thyroiditis and Addison's disease
67. A cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphism is associated with autoimmune Addison's disease in English patients
68. Association analysis of the cytotoxic T lymphocyte antigen-4 (CTLA-4) and autoimmune regulator-1 (AIRE-1) genes in sporadic autoimmune Addison's disease
69. CTLA-4 in autoimmune diseases - A general susceptibility gene to autoimmunity
70. Autoantibodies against aromatic L-amino acid decarboxylase identifies a subgroup of patients with Addison's disease
71. Adrenal autoimmunity: Results and developments
72. Screening for an AIRE-1 mutation in patients with Addison's disease, type 1 diabetes, Graves' disease and Hashimoto's thyroiditis as well as in APECED syndrome
73. Newborn screening for HLA markers associated with IDDM: Diabetes Autoimmunity Study in the Young (DAISY)